Leadiant Biosciences
Manufacturing · Maryland, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
530 Gaither Rd Ste 300, Rockville, Maryl...Phone Number
(800) 447-0169Website
www.leadiant.comRevenue
$22.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
2
1
2
1
1
About Leadiant Biosciences
Leadiant Biosciences, Inc. is a research-based pharmaceutical company that focuses on developing and distributing novel therapies for patients with rare diseases. The company is committed to patient-centric care, offering resources and educational support to patients and their families throughout their treatment journeys. Leadiant's product portfolio includes therapies such as Abelcet, Carnitor, Cystaran, and Matulane. Their dedication to innovation is underscored by partnerships with healthcare professionals, researchers, and academic organizations globally.Explore more
Leadiant Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Leadiant Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Leadiant Biosciences
Earning: See what the market has to say on Leadiant Biosciences recently announced quarterly report
Click to see if Leadiant Biosciences had a recent Job posting/layoffs
Check if Leadiant Biosciences has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Leadiant Biosciences launches new products
Funding: Get notified immidiatlly once Leadiant Biosciences has new funding data
Website visits: Recent activity has been detected on your website
Check out if Leadiant Biosciences is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Leadiant Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Leadiant Biosciences
Compare insights from companies similar to Leadiant Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$33.7M
201-500
Private
-
2003
MP
Marc PaupeCo-President & Les Jeunes Philanthropes DE L'Iric Board Member
Company Profile Activity
Activity Insights
Leadiant Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Leadiant Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Leadiant Biosciences.
Leadiant Biosciences Tech Stack
A closer look at the technologies used by Leadiant Biosciences
See more technologies
Most Recent Scoops
Partnership
Leadiant Biosciences is planning to collaborate with National Institutes of Health in a cooperative research and development agreement (CRADA) aimed at developing N-acetyl-D-mannosamine (ManNAc) for the treatment of GNE myopathy.
Partnership, Research & Development
Left Company
Tim Owens, Manager, Information Technology, has left the organization.
Personnel Moves, Left Company
Project
Project
Cloud, IT Contracts, Collaboration/Web Apps, Unified Communications
Leadiant Biosciences News & Media
Healthcare Nanotechnology Market to See Huge Growth by 2026 : Leadiant Biosciences, Biogen, Kyowa Hakko Kirin
Edison, NJ -- (SBWIRE) -- 03/18/2021 -- Global Healthcare Nanotechnology Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread) is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and onLeadiant Biosciences Is Conducting the Registry Study of Revcovi® Treatment in Patients With ADA-SCID
GAITHERSBURG, Md.--(BUSINESS WIRE)--Leadiant Biosciences, Inc. announced it is conducting the Registry Study of Revcovi® (elapegademase-lvlr) Treatment in Patients with ADA-SCID.FDA Approves Revcovi™, a New Enzyme Replacement Therapy Developed by Leadiant Biosciences, for the Treatment of ADA-SCID in Pediatric and Adult Patients
GAITHERSBURG, Md.--(BUSINESS WIRE)--Leadiant today announced that the FDA has granted approval to Revcovi injection in the U.S. Revcovi is a new ERT for the treatment of ADA-SCID.Leadiant Biosciences to Collaborate with National Institutes of Health on Therapy in Late-Stage Development for GNE Myopathy
GAITHERSBURG, Md.--(BUSINESS WIRE)--Leadiant today announced it has entered into an agreement with NIH to develop ManNAc for the potential treatment of individuals with GNE myopathy.
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Leadiant Biosciences
Sign Up For FreeTo access detailed company insights
Leadiant Biosciences, Inc. is a research-based pharmaceutical company that focuses on developing and distributing novel therapies for patients with rare diseases. The company is committed to patient-centric care, offering resources and educational support to patients and their families throughout their treatment journeys. Leadiant's product portfol... Read More
